Skip to main content

Table 5 Model base case results by country, simulated cohort

From: Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries

 

Delta Cost [€] per participant

Delta QALY per 1000 participants

Strokes prevented per 1000 participants

ICER [€/year] (Delta cost per QALY)

Switzerland

−74.91

10.5

2.52

Scrrening dominates

UK

−6.81

12.6

3.06

Greece

5.97

12.2

3.05

€489

Netherlands

15.44

10.1

2.48

€1529

Poland

19.90

18.7

4.43

€1064

Serbia

33.13

13.0

3.43

€2548

Germany *

5.63

14.7

3.65

€382

  1. Simulated cohort: 65–85 years, determined by general age distribution and AF prevalence by age
  2. *Germany: model assumptions adopted from [36] (disregarding the risk structure compensation effect)